FDA Adverse Event Malfunction Summary report: N

WAYPOINT STEREOTACTIC SYSTEM

MDR report key: 4121854 · Received July 31, 2014

Report

Report Number
3005677147-2014-00005
Event Type
Malfunction
Date Received
July 31, 2014
Date of Event
July 1, 2014
Report Date
July 25, 2014
Manufacturer
FHC, INC.
Product Code
GZL
PMA / PMN Number
K033173
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ME, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

EVALUATION OF THE RETURNED PLATFORM, PRE-OP PLANS AND POST-OP IMAGES SUGGESTS THAT THE LEAD WAS IMPLANTED ALONG THE INTENDED TARGET BUT WAS AT THE INCORRECT DEPTH AND MAY HAVE SLIPPED AT SOME POINT DURING IMPLANTATION. NO ISSUES WERE FOUND WITH THE PLATFORM OR OTHER EQUIPMENT USED IN THE CASE. NO ADVERSE EFFECTS WERE NOTED WITH THE PATIENT, HOWEVER, THE PATIENT WAS RESCHEDULED FOR SURGERY TO REVISE THE PLACEMENT OF THE LEAD. REVISION WAS SUCCESSFULLY PERFORMED ON (B)(6) 2014 WITH NO ISSUES. ON (B)(6) 2014 - FHC REPRESENTATIVE ATTENDED REVISION AND DISCUSSED THE EVENT WITH THE PHYSICIAN. NO DEFINITIVE CAUSE OF THE INCORRECT DEPTH OF THE LEAD COULD BE DETERMINED. HOWEVER, THE SCRUB NURSE THAT USUALLY MEASURES THE LEAD WITH THE FHC MEASUREMENT TOOLS WAS ON VACATION DURING THE EVENT. FHC REPRESENTATIVE REVIEWED THE LEAD MEASUREMENT STEPS WITH THE STAFF.

Description of Event or Problem · 1

DR (B)(6) REPORTED THAT DURING A DBS PROCEDURE - LEFT STN, THE LEAD WAS IMPLANTED OFF THE INTENDED TARGET. FHC EQUIPMENT USED WAS WAYPOINT PLATFORM, MT CONTROLLER AND STARDRIVE. MISPLACED LEADS WERE IDENTIFIED DURING POSTOP CT AS BEING APPROXIMATELY 30MM INFERIOR TO INTENDED TARGET. PRIOR TO CT, THEY DID NOT SUSPECT ANY ISSUES. NO ADVERSE EFFECTS ON THE PATIENT HOWEVER THE PATIENT WAS RESCHEDULED FOR SURGERY TO REVISE THE PLACEMENT OF THE LEAD. REVISION WAS SUCCESSFULLY PERFORMED ON (B)(6) 2014 WITH NO ISSUES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
449133 WAYPOINT STEREOTACTIC SYSTEM STEREOTACTIC SYSTEM GZL FHC, INC.

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention